Dr Andrew Barbour
NHMRC Clinical Trials Centre, Sydney Medical School
- Personalising care in resectable pancreas cancer. GAP-T: a study of imaging and molecular biomarkers to guide treatment of patients receiving preoperative chemotherapy followed by surgery.; Barbour A, Goldstein D, Goldstein D, Kench J, Yip S, Brown C, Hicks R, Chang D; National Health and Medical Research Council (NHMRC)/Project Grants.
- DOCetaxel with or without radiation Therapy for resectable Oesophageal adenocarcinoma based on early PET Response to induction chemotherapy (DOCTOR); Goldstein D, Brown C, Yip S, Barbour A; National Health and Medical Research Council (NHMRC)/Project Grants.